Literature DB >> 3297274

Severe falciparum malaria.

J Philpott, J S Keystone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3297274      PMCID： PMC1492645     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania.

Authors:  E Stahel; A Degrémont; U Lagler
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

2.  Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis.

Authors:  T E Peto; C F Gilks
Journal:  Lancet       Date:  1986-05-31       Impact factor: 79.321

3.  Clindamycin activity against chloroquine-resistant Plasmodium falciparum.

Authors:  L S Seaberg; A R Parquette; I Y Gluzman; G W Phillips; T F Brodasky; D J Krogstad
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

4.  Quinidine in falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; T Chongsuphajaisiddhi; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

5.  Quinine loading dose in cerebral malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; M J Warrell; P Chanthavanich; D Bunnag; T Harinasuta
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

6.  Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.

Authors:  R E Phillips; D A Warrell; N J White; S Looareesuwan; J Karbwang
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

7.  Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients.

Authors:  D A Warrell; S Looareesuwan; M J Warrell; P Kasemsarn; R Intaraprasert; D Bunnag; T Harinasuta
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.